SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Video: How to treat kidney disease?

2.

Studies point to redlining as a 'perfect storm' for breast cancer

3.

Can Alternating Venetoclax Regimens Improve AML Outcomes?

4.

In breast-conserving surgery, is micro-CT a useful tool for determining tumor margins?

5.

Kekoa Taparra, a native Hawaiian physician-scientist, is becoming well-known.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot